Plasma levels of soluble programmed death ligand 1 (sPD-L1) in WHO II/III nasopharyngeal carcinoma (NPC): A preliminary study

Plasma levels of soluble PD-L1 (sPD-L1) have been reported to be an independent prognostic factor in many malignant tumors. The expression of sPD-L1 in nasopharyngeal carcinoma (NPC) has not been reported. The purpose of this study was to evaluate the expression of sPD-L1 and analyze its correlation...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Jia, Hu, Man, Bai, Xinbin, Ding, Xingchen, Xie, Li, Ma, Ji, Fan, Bingjie, Yu, Jinming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2019
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775345/
https://www.ncbi.nlm.nih.gov/pubmed/31574833
http://dx.doi.org/10.1097/MD.0000000000017231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6775345/
https://www.ncbi.nlm.nih.gov/pubmed/31574833
http://dx.doi.org/10.1097/MD.0000000000017231

Ejemplares similares